跳至主要内容
临床试验/NCT01688778
NCT01688778已完成不适用

The Copenhagen Rehabilitation Trial Part 2: Telemedicine as a Means to Achieve Good Diabetes Control Among Patients With Type 2 Diabetes

Bispebjerg Hospital2 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2012年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
165
试验地点
2
主要终点
Changes in HbA1c

研究概览

简要总结

The aim of the study is to investigate the effect of telemedicine among the group of type-2-diabetics who, despite rehabilitation, remain poorly regulated. To describe the patients with regards to vulnerability and social resources and to determine wich groups benefit the most from telemedicine.

详细描述

Type-2-diabetes is a growing healthcare problem. Both because of the increasing amount of patients and because of the complications of diabetes.

Non-pharmacological treatment is considered fundamental in the treatment of patients with type-2-diabetes.

In the Community of Copenhagen, all patients diagnosed with diabetes receive rehabilitation. The rehabilitation consists of counseling with regards to nutrition, physical activity, smoking cessation and education about diabetes.

Some patients however, remain poorly regulated despite rehabilitation as well as pharmacological treatment.

A total number of 165 patients will be randomized to intervention group or standard care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HbA1c > 7,5%
  • BMI > 25
  • Spoken danish
  • Completed a rehabilitation program more than 6 months ago

排除标准

  • HbA1c < 7,5%
  • BMI < 25
  • Need of interpreter

研究组 & 干预措施

Telemedicine

Experimental

Monthly video consultations with a nurse as add-on to standard treatment.

干预措施: Telemedicine (Behavioral)

Standard treatment

No Intervention

Standard diabetes control at a Diabetes Clinic or GP

结局指标

主要结局

Changes in HbA1c

时间窗: Baseline, 16 weeks, 32 weeks, 6 months after intervention

次要结局

  • Use of medication(Baseline, 32 weeks)
  • Body mass index(Baseline, 32 weeks)
  • Beta-cell function test (HOMA)(Baseline, 32 weeks)
  • Weight(Baseline, 32 weeks)
  • Bloodpressure(Baseline, 32 weeks)
  • Fasting total cholesterol, LDL, HDL, triglycerides(Baseline, 32 weeks)
  • Physical activity(Baseline, 32 weeks)
  • Hip circumference(Baseline, 32 weeks)
  • Change in quality of life(Baseline, 32 weeks)
  • Waist circumference(Baseline, 32 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Caroline Raun Hansen

MD

Bispebjerg Hospital

研究点 (2)

Loading locations...

相似试验